Charles Piller
Investigative Correspondent at Science Magazine
Investigative reporter @sciencemagazine. Author of "Doctored" [email protected] - Signal 510.469.7984 - open DMs.
Articles
-
2 months ago |
medcentral.com | Marc E. Agronin |Ivan Oransky |Charles Piller |Greg Sackuvich
The oral NMDA receptor antagonist/sigma-1 receptor agonist AXS-05 significantly delayed and prevented Alzheimer’s disease agitation relapse compared with placebo, according to results of the ACCORD-2 trial presented at the 2025 American Academy of Neurology annual meeting held in San Diego this week. “These results support the use of AXS-05 as a safe and effective treatment for AD agitation,” said George Grossberg, MD, of Saint Louis University School of Medicine, St. Louis, MO.
-
Mar 25, 2025 |
thetransmitter.org | Angie Voyles Askham |Calli McMurray |Charles Piller |Brendan Borrell
Three researchers who served as scientific advisers to the U.S. National Institute of Mental Health (NIMH) were removed from their positions this week, The Transmitter has learned. At least one adviser to the National Institute on Drug Abuse (NIDA) was also terminated this week. The researchers each received a letter this week from Matthew Memoli, acting director of the U.S. National Institutes of Health (NIH), dated 21 March.
-
Mar 25, 2025 |
thetransmitter.org | Angie Voyles Askham |Calli McMurray |Charles Piller |Brendan Borrell
Three researchers who served as scientific advisers to the U.S. National Institute of Mental Health (NIMH) were removed from their positions this week, The Transmitter has learned. At least two advisers to the National Institute on Drug Abuse (NIDA) were also terminated this week. The researchers each received a letter this week from Matthew Memoli, acting director of the U.S. National Institutes of Health (NIH), dated 21 March.
-
Mar 7, 2025 |
thetransmitter.org | Angie Voyles Askham |Charles Piller |Calli McMurray
Matthew Memoli, acting director of the U.S. National Institutes of Health (NIH), has extended the appointments of three NIH neuroscience lab heads and other employees who were set to be terminated tomorrow, according to an email obtained by The Transmitter. The move comes after a group of nine neuroscientists sent a letter to Memoli and the U.S. Congress on Tuesday, asking them to intervene.
-
Mar 4, 2025 |
thetransmitter.org | Sydney Wyatt |Charles Piller |Calli McMurray |Angie Voyles Askham
I learned about the Stand Up for Science movement through one of my classmates. She told me that they needed people to spread the message. I’m trying to start doing that in Florida, which is where I grew up. There’s a lot of pent-up energy, but people don’t know how to move forward right now. Protesting is a way to let that out and to find a community of other people who also need to do that. I was born in China, but I was adopted by my family, and we’re Argentinian.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 4K
- DMs Open
- Yes
U.S. aid helped two African countries rein in HIV. Then came Trump | Science | AAAS - important reporting by @sciencecohen https://t.co/Fp4t0ugvDm
RT @OxygenIvan: @schrag_matthew @cpiller Ditto! And hats off to Dr. Schrag for his role, extensively documented in the book.
Another retracted paper by former NIA Neuroscience head Eliezer Masliah, et al. One of 132 suspect papers featured in my 2024 investigation for @NewsfromScience based largely on work by forensic image experts. Key findings on this one by @Thatsregrettab1 https://t.co/oIAmvWRpN4
